Interleukin-13 Receptor Alpha 2 (IL-13Rα2) is highly expressed in glioblastoma tumor cells but is seldom found in normal brain cells, making it a compelling target for CAR-T cell therapy in glioblastoma cancer. This evidence concerns the gene IL13RA2 and neoplasm.